News

The VITALITY-ALS (Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices after Treatment for a Year in ALS) is a phase 3 clinical trial of tirasemtiv in patients

The company received formal notification from AEMPS for an extension to its licence 6458E: Manufacturer of Investigational Medicinal Products, to include the manufacture of monodispersed controlled release microcapsules,

Through the study, it was discovered that people who used lansoprazole, a widely used gastric acid suppressant were a third less likely to get TB, as opposed to

People in France, the Netherlands, Spain, Sweden, Switzerland and UK can now take part in the study, which aims to develop tests to identify early signs of Alzheimer’s

Juluca is said to be the first 2DR, which includes dolutegravir 50mg produced by ViiV Healthcare and rilpivirine 25mg produced by Janssen Therapeutics. Dolutegravir 50mg is an integrase

Fresenius Kabi, a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition, will expand its manufacturing operations in Wilson County, Governor

The application seeks to broaden the existing marketing authorisation to include daratumumab in combination with bortezomib, melphalan and prednisone for the treatment of adult patients with newly diagnosed

The CMA has provisionally found that Concordia overcharged the NHS by millions for the thyroid drug by increasing the price of a pack of liothyronine tablets from about £4.46 prior to its

Tasigna has also been approved for the treatment of pediatric patients with Ph+ CML-CP with resistance or intolerance to prior therapy including imatinib. Tasigna said to be the